NYSE:MET - Metlife Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$45.57 +0.71 (+1.58 %)
(As of 08/17/2018 09:04 AM ET)
Previous Close$44.86
Today's Range$45.15 - $45.82
52-Week Range$43.09 - $55.91
Volume5.36 million shs
Average Volume6.17 million shs
Market Capitalization$44.42 billion
P/E Ratio10.13
Dividend Yield3.73%
Beta1.23
Metlife logoMetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
SymbolNYSE:MET
CUSIP59156R10
Phone212-578-9500

Debt

Debt-to-Equity Ratio0.29
Current Ratio0.15
Quick Ratio0.15

Price-To-Earnings

Trailing P/E Ratio10.13
Forward P/E Ratio8.73
P/E Growth0.68

Sales & Book Value

Annual Sales$62.09 billion
Price / Sales0.73
Cash Flow$4.5707 per share
Price / Cash9.97
Book Value$55.94 per share
Price / Book0.81

Profitability

EPS (Most Recent Fiscal Year)$4.50
Net Income$4.01 billion
Net Margins6.12%
Return on Equity9.17%
Return on Assets0.73%

Miscellaneous

Employees49,000
Outstanding Shares994,840,000
Market Cap$44.42 billion

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.69%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, May 22nd 2018, which permits the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 3.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's management believes its shares are undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) posted its earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 EPS for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.13. The financial services provider had revenue of $21.22 billion for the quarter, compared to analyst estimates of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. Metlife's quarterly revenue was up 36.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.04 earnings per share. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

15 brokers have issued 12 month price targets for Metlife's stock. Their forecasts range from $48.00 to $67.00. On average, they anticipate Metlife's share price to reach $55.2857 in the next twelve months. This suggests a possible upside of 21.3% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife earnings beat the Zacks Consensus Estimate by 11.1% and improved 25% year over year on prudent underwriting and expense management. MetLife’s shares have gained when compared to its industry’s growth in six month’s time. Moreover, the company has witnessed its 2018 estimates move upward over the last seven days. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 after declining for two years and the trend is likely to continue in 2018. Its strong international operations and disciplined capital management should drive long-term growth. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins." (8/9/2018)
  • 2. Wells Fargo & Co analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018)

Are investors shorting Metlife?

Metlife saw a increase in short interest during the month of July. As of July 13th, there was short interest totalling 14,206,280 shares, an increase of 18.2% from the June 29th total of 12,020,301 shares. Based on an average daily trading volume, of 4,474,570 shares, the short-interest ratio is presently 3.2 days. Approximately 1.6% of the shares of the stock are short sold. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
  • Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 58)
  • Mr. Steven Jeffery Goulart, Exec. VP & Chief Investment Officer (Age 59)
  • Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 54)
  • Mr. John Carroll Ramsey Hele, Sr. Adviser (Age 60)

Has Metlife been receiving favorable news coverage?

News headlines about MET stock have trended somewhat positive on Friday, Accern reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Metlife earned a media and rumor sentiment score of 0.24 on Accern's scale. They also assigned news stories about the financial services provider an impact score of 48.16 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Metlife.

Who are Metlife's major shareholders?

Metlife's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.11%), FMR LLC (4.60%), Massachusetts Financial Services Co. MA (2.41%), Bank of New York Mellon Corp (1.28%), Diamond Hill Capital Management Inc. (1.04%) and Epoch Investment Partners Inc. (0.87%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Epoch Investment Partners Inc., BlackRock Inc., Canada Pension Plan Investment Board, Bank of Montreal Can, Jennison Associates LLC, Caisse DE Depot ET Placement DU Quebec and United Services Automobile Association. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Morgan Stanley, Robeco Institutional Asset Management B.V., Putnam Investments LLC, Sumitomo Mitsui Trust Holdings Inc., LSV Asset Management and First Trust Advisors LP. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $45.57.

How big of a company is Metlife?

Metlife has a market capitalization of $44.42 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

How can I contact Metlife?

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  713 (Thanks for Voting!)
Underperform Votes:  434 (Thanks for Voting!)
Total Votes:  1,147
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.